Hindsight is 20/20 - the importance of knowing! Know your patients' HBV status

Meta-Analysis: High anti-HBs Titers are Associated with Significantly Reduced Risk of Hepatitis B Virus Reactivation During Rituximab Treatment.

Alimentary pharmacology & therapeutics·2025

Investigation of the Role of Chemical Analysis in Causality Assessment of Herbal and Dietary Supplement-Induced Liver Injury.

Drug safety·2024

Review article: Recommendations for detection, assessment and management of suspected drug-induced liver injury during clinical trials in oncology patients.

Alimentary pharmacology & therapeutics·2024

Trends in mortality from gastrointestinal, hepatic, and pancreatic cancers in the United States: A comprehensive analysis (1999-2020).

JGH open : an open access journal of gastroenterology and hepatology·2024

Liver toxicity in oncology trials and beyond: a simplified concept for management of hepatocellular drug-induced liver injury in patients with abnormal baseline liver tests.

Expert opinion on drug safety·2024

Size Matters! Anti-HBs Titer and HBV Reactivation During Anti-TNF Therapy.

Digestive diseases and sciences·2023

COMbination therapy with baloxavir and oseltamivir 1 for hospitalized patients with influenza: The pragmatic COMBO 1 randomized controlled trial.

Antiviral therapy·2026

Week 96 resistance analysis in participants receiving bictegravir/lenacapavir in the phase 2 ARTISTRY-1 study.

Antiviral therapy·2026

Safety and efficacy of deltoid intramuscular long-acting cabotegravir and rilpivirine, a case series.

Antiviral therapy·2026

Factors associated with immunological non-response in HIV patients receiving antiretroviral therapy in Southeast Asia: A systematic review.

Antiviral therapy·2026

Epidemiology and clinical management of cytomegalovirus infection in transplant recipients in Central and Eastern Europe - a physician survey.

Antiviral therapy·2026

It's about time: The association between abacavir and cardiovascular disease.

Antiviral therapy·2026

Reframing Technology and Ethics in Corneal Xenotransplantation: A Scoping Review of Standards and Safety in Ophthalmology.

Health care science·2026

Can Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis be Treated More Successfully?

Public health challenges·2026

Rethinking tau-targeted therapy in Alzheimer's disease: Toward a dual biomarker strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Pathological Signal-Responsive Nanoplatforms for Sepsis: Integrating Biomarker Sensing With Spatiotemporal Drug Delivery and Immunomodulation.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Medical Device Safety Throughout the Product Lifecycle: Regulatory Frameworks, Digital Transformation, and the Role of Artificial Intelligence in Devices and Monitoring.

Clinical therapeutics·2026

Infectious risks of transfusion: a 10-year look back and perspectives.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026

Related Experiment Videos

Hindsight is 20/20 - the importance of knowing! Know your patients' HBV status

Related Concept Videos

Meta-Analysis: High anti-HBs Titers are Associated with Significantly Reduced Risk of Hepatitis B Virus Reactivation During Rituximab Treatment.

Investigation of the Role of Chemical Analysis in Causality Assessment of Herbal and Dietary Supplement-Induced Liver Injury.

Review article: Recommendations for detection, assessment and management of suspected drug-induced liver injury during clinical trials in oncology patients.

Trends in mortality from gastrointestinal, hepatic, and pancreatic cancers in the United States: A comprehensive analysis (1999-2020).

Liver toxicity in oncology trials and beyond: a simplified concept for management of hepatocellular drug-induced liver injury in patients with abnormal baseline liver tests.

Size Matters! Anti-HBs Titer and HBV Reactivation During Anti-TNF Therapy.

COMbination therapy with baloxavir and oseltamivir 1 for hospitalized patients with influenza: The pragmatic COMBO 1 randomized controlled trial.

Week 96 resistance analysis in participants receiving bictegravir/lenacapavir in the phase 2 ARTISTRY-1 study.

Safety and efficacy of deltoid intramuscular long-acting cabotegravir and rilpivirine, a case series.

Factors associated with immunological non-response in HIV patients receiving antiretroviral therapy in Southeast Asia: A systematic review.

Epidemiology and clinical management of cytomegalovirus infection in transplant recipients in Central and Eastern Europe - a physician survey.

It's about time: The association between abacavir and cardiovascular disease.

Reframing Technology and Ethics in Corneal Xenotransplantation: A Scoping Review of Standards and Safety in Ophthalmology.

Can Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis be Treated More Successfully?

Rethinking tau-targeted therapy in Alzheimer's disease: Toward a dual biomarker strategy.

Pathological Signal-Responsive Nanoplatforms for Sepsis: Integrating Biomarker Sensing With Spatiotemporal Drug Delivery and Immunomodulation.

Medical Device Safety Throughout the Product Lifecycle: Regulatory Frameworks, Digital Transformation, and the Role of Artificial Intelligence in Devices and Monitoring.

Infectious risks of transfusion: a 10-year look back and perspectives.

Related Experiment Videos

Hindsight is 20/20 - the importance of knowing! Know your patients' HBV status

Related Concept Videos

Related Articles